Business Context and Reporting Period
This Form 6-K filing by Prana Biotechnology Limited (ASX Code: PBT) covers the month of August 2013. The registrant is a foreign private issuer based in Australia. The filing serves as a "Cleansing Notice" under Section 708A(5) of the Corporations Act 2001 (Cth) regarding a specific share issuance.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or debt metrics. The only specific financial data disclosed relates to a share issuance event:
- Shares Issued: 2,517,590 Ordinary Fully Paid Shares
- Issue Date: August 7, 2013
- Total Proceeds: AUD$963,097
Material Changes
The primary material change reported is the issuance of 2,517,590 ordinary shares without prior disclosure to investors under Part 6D.2 of the Corporations Act. The company confirms compliance with Chapter 2M and Section 674 of the Corporations Act as of the notice date.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, or outlook. Regarding risks and contingencies, the company explicitly states that as of the notice date, there is no "excluded information" required to be disclosed under subsection 708A(7) of the Corporations Act.
Investor Verification Checklist
- Verify the current share capital structure to confirm the inclusion of the 2,517,590 shares issued on August 7, 2013.
- Confirm the utilization of the AUD$963,097 raised from this issuance.
- Review subsequent filings to ensure no "excluded information" has emerged since the cleansing notice date.